308 related articles for article (PubMed ID: 23152192)
21. Long-term nucleus basalis cholinergic depletion induces attentional deficits and impacts cortical neurons and BDNF levels without affecting the NGF synthesis.
Orciani C; Hall H; Pentz R; Foret MK; Do Carmo S; Cuello AC
J Neurochem; 2022 Oct; 163(2):149-167. PubMed ID: 35921478
[TBL] [Abstract][Full Text] [Related]
22. Compromise of cortical proNGF maturation causes selective retrograde atrophy in cholinergic nucleus basalis neurons.
Allard S; Jacobs ML; Do Carmo S; Cuello AC
Neurobiol Aging; 2018 Jul; 67():10-20. PubMed ID: 29609077
[TBL] [Abstract][Full Text] [Related]
23. The role of nerve growth factor receptors in cholinergic basal forebrain degeneration in prodromal Alzheimer disease.
Counts SE; Mufson EJ
J Neuropathol Exp Neurol; 2005 Apr; 64(4):263-72. PubMed ID: 15835262
[TBL] [Abstract][Full Text] [Related]
24. The hAPP-YAC transgenic model has elevated UPS activity in the frontal cortex similar to Alzheimer's disease and Down's syndrome.
Seo H; Isacson O
J Neurochem; 2010 Sep; 114(6):1819-26. PubMed ID: 20698932
[TBL] [Abstract][Full Text] [Related]
25. The neuroprotective effects of Cerebrolysin in a transgenic model of Alzheimer's disease are associated with improved behavioral performance.
Rockenstein E; Adame A; Mante M; Moessler H; Windisch M; Masliah E
J Neural Transm (Vienna); 2003 Nov; 110(11):1313-27. PubMed ID: 14628195
[TBL] [Abstract][Full Text] [Related]
26. Selective vulnerability in Alzheimer's disease: amyloid precursor protein and p75(NTR) interaction.
Fombonne J; Rabizadeh S; Banwait S; Mehlen P; Bredesen DE
Ann Neurol; 2009 Mar; 65(3):294-303. PubMed ID: 19334058
[TBL] [Abstract][Full Text] [Related]
27. Neurofibrillary and neurodegenerative pathology in APP-transgenic mice injected with AAV2-mutant TAU: neuroprotective effects of Cerebrolysin.
Ubhi K; Rockenstein E; Doppler E; Mante M; Adame A; Patrick C; Trejo M; Crews L; Paulino A; Moessler H; Masliah E
Acta Neuropathol; 2009 Jun; 117(6):699-712. PubMed ID: 19252918
[TBL] [Abstract][Full Text] [Related]
28. Highly selective effects of nerve growth factor, brain-derived neurotrophic factor, and neurotrophin-3 on intact and injured basal forebrain magnocellular neurons.
Koliatsos VE; Price DL; Gouras GK; Cayouette MH; Burton LE; Winslow JW
J Comp Neurol; 1994 May; 343(2):247-62. PubMed ID: 8027442
[TBL] [Abstract][Full Text] [Related]
29. Cholinotrophic molecular substrates of mild cognitive impairment in the elderly.
Mufson EJ; Counts SE; Fahnestock M; Ginsberg SD
Curr Alzheimer Res; 2007 Sep; 4(4):340-50. PubMed ID: 17908035
[TBL] [Abstract][Full Text] [Related]
30. The Intersection of NGF/TrkA Signaling and Amyloid Precursor Protein Processing in Alzheimer's Disease Neuropathology.
Canu N; Amadoro G; Triaca V; Latina V; Sposato V; Corsetti V; Severini C; Ciotti MT; Calissano P
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28632177
[TBL] [Abstract][Full Text] [Related]
31. Activation of TrkA by nerve growth factor upregulates expression of the cholinergic gene locus but attenuates the response to ciliary neurotrophic growth factor.
Berse B; Lopez-Coviella I; Blusztajn JK
Biochem J; 1999 Sep; 342 ( Pt 2)(Pt 2):301-8. PubMed ID: 10455015
[TBL] [Abstract][Full Text] [Related]
32. Neurotrophic factors in Alzheimer's disease: role of axonal transport.
Schindowski K; Belarbi K; Buée L
Genes Brain Behav; 2008 Feb; 7 Suppl 1(1):43-56. PubMed ID: 18184369
[TBL] [Abstract][Full Text] [Related]
33. Neuropathology of mice carrying mutant APP(swe) and/or PS1(M146L) transgenes: alterations in the p75(NTR) cholinergic basal forebrain septohippocampal pathway.
Jaffar S; Counts SE; Ma SY; Dadko E; Gordon MN; Morgan D; Mufson EJ
Exp Neurol; 2001 Aug; 170(2):227-43. PubMed ID: 11476589
[TBL] [Abstract][Full Text] [Related]
34. NGF and the Amyloid Precursor Protein in Alzheimer's Disease: From Molecular Players to Neuronal Circuits.
Triaca V; Ruberti F; Canu N
Adv Exp Med Biol; 2021; 1331():145-165. PubMed ID: 34453297
[TBL] [Abstract][Full Text] [Related]
35. Dexamethasone induces hypertrophy of developing medial septum cholinergic neurons: potential role of nerve growth factor.
Shi B; Rabin SJ; Brandoli C; Mocchetti I
J Neurosci; 1998 Nov; 18(22):9326-34. PubMed ID: 9801371
[TBL] [Abstract][Full Text] [Related]
36. Pacinian corpuscle development involves multiple Trk signaling pathways.
Sedý J; Szeder V; Walro JM; Ren ZG; Nanka O; Tessarollo L; Sieber-Blum M; Grim M; Kucera J
Dev Dyn; 2004 Nov; 231(3):551-63. PubMed ID: 15376326
[TBL] [Abstract][Full Text] [Related]
37. Disease modifying effect of chronic oral treatment with a neurotrophic peptidergic compound in a triple transgenic mouse model of Alzheimer's disease.
Kazim SF; Blanchard J; Dai CL; Tung YC; LaFerla FM; Iqbal IG; Iqbal K
Neurobiol Dis; 2014 Nov; 71():110-30. PubMed ID: 25046994
[TBL] [Abstract][Full Text] [Related]
38. IGF2 ameliorates amyloidosis, increases cholinergic marker expression and raises BMP9 and neurotrophin levels in the hippocampus of the APPswePS1dE9 Alzheimer's disease model mice.
Mellott TJ; Pender SM; Burke RM; Langley EA; Blusztajn JK
PLoS One; 2014; 9(4):e94287. PubMed ID: 24732467
[TBL] [Abstract][Full Text] [Related]
39. Focused ultrasound delivery of a selective TrkA agonist rescues cholinergic function in a mouse model of Alzheimer's disease.
Xhima K; Markham-Coultes K; Nedev H; Heinen S; Saragovi HU; Hynynen K; Aubert I
Sci Adv; 2020 Jan; 6(4):eaax6646. PubMed ID: 32010781
[TBL] [Abstract][Full Text] [Related]
40. Small molecule modulation of TrkB and TrkC neurotrophin receptors prevents cholinergic neuron atrophy in an Alzheimer's disease mouse model at an advanced pathological stage.
Gonzalez S; McHugh TLM; Yang T; Syriani W; Massa SM; Longo FM; Simmons DA
Neurobiol Dis; 2022 Jan; 162():105563. PubMed ID: 34838668
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
